Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lippi
Massimo Franchini

Showing results (1-10 of 2,519) with videos related to

Pageof 252
Sort By:
Advances in Clinical Chemistry|August 31, 2011
Acquired hemophilia AMassimo Franchini, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis|April 2, 2011
Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage?Massimo Franchini, Giuseppe Lippi
Blood Transfusion = Trasfusione Del Sangue|August 16, 2011
The use of desmopressin in acquired haemophilia A: a systematic reviewMassimo Franchini, Giuseppe Lippi
Journal of Cellular and Molecular Medicine|February 21, 2009
Are haemophiliacs protected against cancer development? Prospective controlled studies are neededMassimo Franchini, Giuseppe Lippi
Journal of Thrombosis and Thrombolysis|November 6, 2010
Acquired factor V inhibitors: a systematic reviewMassimo Franchini, Giuseppe Lippi
European Journal of Applied Physiology|September 17, 2009
Intermittent hypoxic training: doping or what?Giuseppe Lippi, Massimo Franchini
Seminars in Thrombosis and Hemostasis|July 16, 2010
Recombinant activated factor VII: mechanisms of action and current indicationsMassimo Franchini, Giuseppe Lippi
Recenti Progressi in Medicina|February 20, 2002
[The new frontiers of blood doping]Giuseppe Lippi, Massimo Franchini
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 5, 2006
Recent acquisitions in acquired and congenital von Willebrand disordersMassimo Franchini, Giuseppe Lippi
The Lancet. Haematology|December 22, 2015
Thalidomide for hereditary haemorrhagic telangiectasiaMassimo Franchini, Giuseppe Lippi
Pageof 252

Showing results (1-10 of 2,519) with videos related to

Sort By:
Pageof 252
Advances in Clinical Chemistry|August 31, 2011
Acquired hemophilia AMassimo Franchini, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis|April 2, 2011
Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage?Massimo Franchini, Giuseppe Lippi
Blood Transfusion = Trasfusione Del Sangue|August 16, 2011
The use of desmopressin in acquired haemophilia A: a systematic reviewMassimo Franchini, Giuseppe Lippi
Journal of Cellular and Molecular Medicine|February 21, 2009
Are haemophiliacs protected against cancer development? Prospective controlled studies are neededMassimo Franchini, Giuseppe Lippi
Journal of Thrombosis and Thrombolysis|November 6, 2010
Acquired factor V inhibitors: a systematic reviewMassimo Franchini, Giuseppe Lippi
European Journal of Applied Physiology|September 17, 2009
Intermittent hypoxic training: doping or what?Giuseppe Lippi, Massimo Franchini
Seminars in Thrombosis and Hemostasis|July 16, 2010
Recombinant activated factor VII: mechanisms of action and current indicationsMassimo Franchini, Giuseppe Lippi
Recenti Progressi in Medicina|February 20, 2002
[The new frontiers of blood doping]Giuseppe Lippi, Massimo Franchini
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 5, 2006
Recent acquisitions in acquired and congenital von Willebrand disordersMassimo Franchini, Giuseppe Lippi
The Lancet. Haematology|December 22, 2015
Thalidomide for hereditary haemorrhagic telangiectasiaMassimo Franchini, Giuseppe Lippi
Pageof 252